WASHINGTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- A new study found that use of the Psychiatric Collaborative Care Model (CoCM) is increasing rapidly at a national level, but enormous disparities in use ...

Speaking at the event on Thursday, Former UK PM Rishi Sunak said said India can lead the way in using AI to tackle the world’s biggest challenges, highlighting its growing capabilities in innovation ...

WASHINGTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- A new study found that use of the Psychiatric Collaborative Care Model (CoCM) is increasing rapidly at a national level, but enormous disparities in use ...

The Justice Department is signaling a broader use of federal civil rights law against protesters accused of disrupting religious worship, with officials pointing to synagogue cases as a model for ...

Economy minister Akmal Nasir said Padu could support the government from a back-end perspective, particularly in improving policy planning and implementation. (Bernama pic) The government will ...

Chief Minister Yogi Adityanath said that the most effective way to give a new leap to the agricultural sector of Uttar Pradesh is to implement ‘oilseed and pulse-based intercropping with sugarcane’ on ...

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded approval from the European Commission (EC) for use in adults aged 18 and over.

A widely watched projection from the Federal Reserve Bank of Atlanta got a downgrade Tuesday after a weak government report on retail spending in December. The latest estimate from the Atlanta Fed’s ...

Technology giant Meta is set to trial premium subscriptions for Instagram, Facebook and WhatsApp users in the coming months in its latest experiment with paid services. The new offerings would give ...

Thierno Barry has vowed to continue to prove his critics wrong and admitted the transition from Spain to England had been a steep learning curve for him. Barry made it four goals in his last five ...

GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for treating certain patients with chronic obstructive pulmonary disease (COPD), ...